Domalski; Martin S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Domalski; Martin S..The latest application filed is for "benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors".

Company Profile

0.10.8

Domalski; Martin S. - Verona NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrahydropyranochromene gamma secretase inhibitors Grant 8,664,411 - Wu , et al. March 4, 2	2014-03-04
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors Grant 8,569,521 - Asberom , et al. October 29, 2	2013-10-29
Benzenesulfonyl-chromane, Thiochromane, Tetrahydronaphthalene And Related Gamma Secretase Inhibitors App 20120264736 - Asberom; Theodros ; et al.	2012-10-18
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors Grant 8,067,621 - Asberom , et al. November 29, 2	2011-11-29
Tetrahydropyranochromene Gamma Secretase Inhibitors App 20110236400 - Wu; Wen-Lian ; et al.	2011-09-29
mGluR1 antagonists as therapeutic agents Grant 7,989,464 - Matasi , et al. August 2, 2	2011-08-02
mGluR1 antagonists as therapeutic agents Grant 7,598,259 - Matasi , et al. October 6, 2	2009-10-06
mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS App 20090192178 - Matasi; Julius J. ; et al.	2009-07-30
mGluR1 antagonists as therapeutic agents Grant 7,485,648 - Matasi , et al. February 3, 2	2009-02-03
Substituted n-aryl amidines as selective D.sub.1 dopamine receptor antagonists for the treatment of obesity and CNS disorders Grant 7,423,149 - Burnett , et al. September 9, 2	2008-09-09
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors App 20070197581 - Asberom; Theodros ; et al.	2007-08-23
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity Grant 7,109,207 - Burnett , et al. September 19, 2	2006-09-19
mGluR1 Antagonists as therapeutic agents App 20060167029 - Matasi; Julius J. ; et al.	2006-07-27
mGluR1 antagonists as therapeutic agents App 20060009477 - Matasi; Julius J. ; et al.	2006-01-12
Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders App 20050137210 - Burnett, Duane A. ; et al.	2005-06-23
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity App 20040024002 - Burnett, Duane A. ; et al.	2004-02-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.